triazoles has been researched along with Retinal Neovascularization in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, JM; Clark, ML; Penn, JS; Yanni, SE | 1 |
| Afzal, A; Caballero, S; Edelhauser, H; Franklin, A; Geroski, D; Grant, MB; Hochhaus, G; Jurczyk, S; Kim, M; Palii, SS; Pardue, M; Shapiro, G | 1 |
| Franklin, AJ; Jetton, TL; Kohn, EC; Kuchemann, CL; Russell, SR | 1 |
| Wiedemann, P | 1 |
4 other study(ies) available for triazoles and Retinal Neovascularization
| Article | Year |
|---|---|
The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.
Topics: Animals; Animals, Newborn; Cell Proliferation; Choroid; Choroidal Neovascularization; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Laser Coagulation; Male; Mice; Neuroglia; Oxygen; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Retinal Neovascularization; Retinal Vessels; Thiophenes; Triazoles; Vascular Endothelial Growth Factor A | 2009 |
Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electroretinography; Epithelial Cells; Female; Humans; Injections, Intraocular; Laminin; Mice; Proteoglycans; Rabbits; Rats; Retina; Retinal Neovascularization; Retinal Vessels; Triazoles | 2010 |
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antineoplastic Agents; Disease Models, Animal; Fluorescein Angiography; Hyperoxia; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Retinal Neovascularization; Retinal Vessels; Triazoles | 2004 |
1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferation.
Topics: Calcium Channel Blockers; Cell Adhesion; Cell Movement; Cell Survival; Daunorubicin; Humans; Immunotoxins; Integrins; Multicenter Studies as Topic; Peptides, Cyclic; Pigment Epithelium of Eye; Retinal Neovascularization; Triazoles; Vitreoretinopathy, Proliferative | 1999 |